The ARIETTA study: baseline demographics in a real-world setting in patients with severe asthma Source: International Congress 2017 – Bronchial asthma management Year: 2017
Baseline characteristics of patients with frequent exacerbations in the POET-COPDÔ trial Source: Annual Congress 2011 - Diagnosis and predictors of COPD exacerbation Year: 2011
Follow-up of patients with uncontrolled asthma: clinical features of asthma patients according to the level of control achieved (the COAS study) Source: Eur Respir J , 49 (3) 1501885; DOI: 10.1183/13993003.01885-2015 Year: 2017
Effect of treatment on morning symptoms in COPD. Correlation between doctors and patients in the evaluation of symptoms. SINCON Study Source: International Congress 2018 – Patient-reported outcomes and scores in COPD Year: 2018
Patients' experiences of asthma exacerbation and management: a qualitative study of severe asthma Source: ERJ Open Res, 7 (2) 00528-2020; 10.1183/23120541.00528-2020 Year: 2021
Reslizumab for uncontrolled eosinophilic asthma in patients who experienced a single exacerbation in the previous year: sub-analysis of two phase 3 trials Source: International Congress 2017 – Asthma management Year: 2017
Diurnal variation of symptoms and impact on morning activities in severe COPD: a pan-European cross-sectional study Source: Annual Congress 2009 - Risk factors for COPD Year: 2009
A quantitative European study to investigate the impact of asthma triggers on the lives of asthma patients Source: Annual Congress 2011 - The work environment in the clinic Year: 2011
Distribution of T2 markers in real-life patients with asthma, COPD and asthma+COPD from the BREATHE study Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020
Relationship between baseline rescue medication use and reductions in COPD exacerbation rates: a subgroup analysis of the ETHOS trial Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies Year: 2021
Understanding patients' perceptions of asthma control: a qualitative study Source: Eur Respir J, 51 (6) 1701346; 10.1183/13993003.01346-2017 Year: 2018
Late Breaking Abstract - Danirixin (GSK1325756) improves respiratory symptoms and health status in mild to moderate COPD – results of a 1 year first time in patient study Source: International Congress 2017 – Primary care management of respiratory symptoms, allergies, inhalers and adherence Year: 2017
Time trends in clinical characteristics of patients with severe asthma: data from the Belgian Severe asthma register (BSAR) Source: International Congress 2018 – Tests and trends in asthma Year: 2018
Analysis of pre-hospital management in hospitalized patients with bronchial asthma (BA) exacerbation: 6-year observational study Source: Eur Respir J 2006; 28: Suppl. 50, 313s Year: 2006
Baseline characteristics of patients admitted for the first time for COPD exacerbation. The ²phenotype and course of COPD² (PAC-COPD) study Source: Annual Congress 2007 - Epidemiology of COPD Year: 2007
Fluctuations in lung function vs. asthma control, exacerbations and severity: An alternate look at phenotyping asthma Source: Annual Congress 2010 - Asthma and COPD: understanding through monitoring Year: 2010
Asthma control: a qualitative study of patients‘ experiences Source: Eur Respir J 2005; 26: Suppl. 49, 671s Year: 2005
Efficacy of tiotropium/olodaterol on sedentary/active time in COPD patients: VESUTO study Source: International Congress 2018 – COPD management Year: 2018
A qualitative study of sleep experiences in subjects with moderate to severe COPD Source: Eur Respir J 2006; 28: Suppl. 50, 738s Year: 2006
Two versus three months rehabilitation with the same number of sessions in patients with moderate to severe COPD: analysis of the results Source: Eur Respir J 2004; 24: Suppl. 48, 244s Year: 2004